
Carto 3 Version 8 offers 3D heart mapping for cardiac ablation procedures. Biosense Webster incorporates it into technology like the Varipulse pulsed field ablation (PFA) system, which is currently under FDA review.
Biosense Webster added new modules to the software, including Carto Elevate and CartoSound FAM. The company designed these modules for efficiency, reproducibility and accuracy in catheter ablation for AFib and other arrhythmias.
CartoSound FAM incorporates the first use of AI in intracardiac ultrasound for Biosense Webster. According to the company, the algorithm enables the automatic generation of the left atrial anatomy before inserting the catheter into the left atrium, saving time while also providing a highly accurate map. The module delivers automated 3D shell creation with its deep learning technology.
The Carto Elevate module incorporates several new features, including multipolar capabilities with the Optrell mapping catheter. This significantly reduces far-field potentials while providing a more accurate activation map for localized unipolar signals. Elevate’s complex signals identification provides efficient, reproducible identification of critical areas of interest. Pattern acquisition automatically tracks arrhythmia burden pre- and post-ablation and the enhanced Confidense module creates optimized maps.
“We are pleased to announce this new version of our Carto 3 system, which reflects our continued focus on harnessing the latest science and technology to advance tools for electrophysiologists to treat cardiac arrhythmias,” said Jasmina Brooks, president, Biosense Webster. “The Carto 3 system has been the cornerstone of catheter ablation procedures for more than a decade, helping electrophysiologists make treatment decisions. This new version advances the Carto 3 mapping and ablation experience through enhanced signal analysis, improved substrate characterization, and utilization of ultrasound technology.”